Clinical Trial Update: Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of single-agent obatoclax mesylate followed by rituximab in previously untreated follicular lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Obatoclax Mesylate (obatoclax mesylate)
• Rituxan (rituximab)

Snippet

Sponsor: Gemin X | Conditions: Lymphoma, Follicular | Phase 2 | Status: COMPLETED